Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 7/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 7/20 | 0.38 |
| ▸ | CLK4 | Q9HAZ1 | 6/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.38 |
| ▸ | USP2 | O75604 | 5/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | SYK | P43405 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | ACACB | O00763 | 2/20 | 0.34 |
| ▸ | ACACA | Q13085 | 2/20 | 0.34 |
| ▸ | PTGES | O14684 | 3/20 | 0.33 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22838473 | 0.90 | CYP1A2 (0.40) | CYP1A2CYP3A4CYP2C19CLK4CYP2D6 | |
| SCHEMBL19905049 | 0.89 | CYP1A2 (0.44) | CYP1A2CYP3A4CYP2C19CLK4CYP2D6 | |
| SCHEMBL19355574 | 0.88 | GPR39 (0.39) | CYP1A2CYP3A4CYP2C19CLK4CYP2D6 | |
| SCHEMBL19355621 | 0.87 | PTGES (0.40) | CYP1A2CYP3A4CYP2C19CLK4CYP2D6 | |
| SCHEMBL19905109 | 0.87 | CYP1A2 (0.39) | CYP1A2CYP3A4CYP2C19CLK4CYP2D6 | |
| SCHEMBL19819884 | 0.87 | CYP1A2 (0.38) | CYP1A2CYP3A4CYP2C19CLK4CYP2D6 | |
| SCHEMBL22838686 | 0.87 | PTGES (0.36) | CYP1A2CYP3A4CYP2C19CLK4CYP2D6 | |
| SCHEMBL19905058 | 0.86 | CYP1A2 (0.38) | CYP1A2CYP3A4CYP2C19CLK4CYP2D6 | |
| SCHEMBL19355492 | 0.86 | NTRK1 (0.37) | CYP1A2CYP3A4CYP2C19CLK4CYP2D6 | |
| SCHEMBL19905362 | 0.85 | CYP1A2 (0.41) | CYP1A2CYP3A4CYP2C19CLK4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3459942-B1 | DNA-PK INHIBITORS | VERTEX PHARMA (US) | 2020-12-30 | — | — | EP | disclosed |
| US-20180193341-A1 | DNA-PK INHIBITORS | VERTEX PHARMACEUTICALS INCORPORATED | 2018-07-12 | — | — | US | disclosed |
| EP-3057959-B1 | DNA-PK INHIBITORS | VERTEX PHARMA (US) | 2018-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180193341-A1 | DNA-PK INHIBITORS | POLK, DTYMK, DCK | CYP1A2 2215/4885CYP3A4 1759/4885CYP2C19 1688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.